Children’s Yale-Brown Obsessive Compulsive Scale (CYBOCS-2)

1. Abstract

The Children’s Yale-Brown Obsessive Compulsive Scale – Second Edition (CY-BOCS-II) represents the gold-standard clinician-rated psychometric instrument specifically engineered to evaluate the nature, phenotype, and dimensional symptom severity of obsessive-compulsive disorder (OCD) in pediatric populations aged 8 to 17 years. Originating from the seminal adult Yale-Brown Obsessive Compulsive Scale (Y-BOCS) formulated by Goodman and colleagues and adapted for youth by Scahill and collaborators, the CY-BOCS underwent substantial structural and psychometric revision to address critical measurement limitations identified in the original instrument. The CY-BOCS-II comprises two primary operational components: an exhaustive semi-structured Symptom Checklist that screens for historical (lifetime) and current (past 30 days) cognitive intrusions and behavioral rituals across multiple phenotypical categories, followed by a 10-item Severity Scale. The Severity Scale is evenly divided into two 5-item subscales: the Obsession Severity Subscale and the Compulsion Severity Subscale. Each subscale assesses five parallel core clinical dimensions: time occupied, symptom-free intervals, subjective distress, functional interference, and degree of internal control.

Departing from the original 5-point metric (0 to 4), the second edition incorporates an expanded 6-point ordinal response format ranging from 0 to 5 per item, yielding subscale totals of 0 to 25 and an aggregate global severity index between 0 and 50. This structural alteration, coupled with replacing the problematic “resistance” construct with “symptom-free interval,” was designed to eliminate psychometric artifacts arising from children who willingly surrendered to compulsions to avoid anxiety. Contemporary psychometric evaluations demonstrate outstanding internal consistency across the instrument, with Cronbach’s alpha and omega coefficients routinely exceeding .86 for the obsession dimension, .89 for the compulsion dimension, and .90 for the total severity composite. Confirmatory factor analyses robustly support a two-factor correlated model (Obsessions and Compulsions) while establishing full structural divergence from depressive and generalized anxiety constructs. This comprehensive review examines the theoretical foundations, administrative architecture, structural validity, factor configurations, and translational clinical utility of the CY-BOCS-II in empirical research and specialized child psychiatric care.

2. Keywords

Children’s Yale-Brown Obsessive Compulsive Scale, CYBOCS-2, pediatric obsessive-compulsive disorder, psychometrics, clinical assessment, semi-structured interview, symptom severity, behavioral rituals, cognitive intrusions, treatment outcome monitoring.

3. Authors

The developmental lineage of the Children’s Yale-Brown Obsessive Compulsive Scale (CY-BOCS) reflects collaborative contributions from psychometricians, developmental psychopathologists, and child and adolescent psychiatrists across several major research institutions:

• Wayne K. Goodman, M.D. — Chair and Professor of Psychiatry and Behavioral Sciences, Baylor College of Medicine, Houston, Texas, USA. Dr. Goodman is the original architect of the Yale-Brown Obsessive Compulsive Scale (Y-BOCS) and served as a senior investigator on the adult and pediatric second-edition revisions.
• Lawrence Scahill, M.S.N., Ph.D. — Professor of Pediatrics and Psychiatry, Emory University School of Medicine and Marcus Autism Center, Atlanta, Georgia; formerly of Yale Child Study Center, Yale University School of Medicine, New Haven, Connecticut, USA. Dr. Scahill spearheaded the initial adaptation and clinical validation of the original CY-BOCS.
• Mark A. Riddle, M.D. — Professor of Psychiatry and Behavioral Sciences and Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. Dr. Riddle co-developed the initial pediatric adaptation with a specific focus on developmental applicability.
• Eric A. Storch, Ph.D. — Professor and Vice Chair of Psychology, Menninger Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, Houston, Texas; formerly at the University of South Florida, St. Petersburg, Florida, USA. Dr. Storch directed the psychometric modernization, structural restructuring, and empirical validation resulting in the second edition (CY-BOCS-II).
• Collaborating Investigators: Additional foundational contributions were made by Steven A. Rasmussen, M.D. (Brown University), Lawrence H. Price, M.D. (Brown University), Tanya K. Murphy, M.D. (University of South Florida), and Sharon Ort, R.N., M.P.H. (Yale Child Study Center).

4. Purpose

The primary purpose of the CY-BOCS-II is to deliver a reliable, psychometrically sound, and developmentally sensitive quantification of obsessive-compulsive symptom severity in children and adolescents. While structured diagnostic manuals such as the Diagnostic and Statistical Manual of Mental Disorders (DSM-5-TR) and the International Classification of Diseases (ICD-11) provide explicit categorical criteria for diagnosing OCD, they offer limited insight into the continuous gradient of symptom severity, the operational impairment across settings, or subtle longitudinal fluctuations in response to intervention. The CY-BOCS-II was deliberately engineered to dissociate symptom content (the specific thematic typology of obsessions and rituals) from symptom severity (the degree of temporal intrusion, functional distress, ecological impairment, and regulatory agency).

In clinical trials and translational research, the CY-BOCS-II operates as the undisputed benchmark primary outcome measure. Major multi-site landmark investigations—such as the Pediatric OCD Treatment Study (POTS I and POTS II)—utilized the instrument to gauge the comparative efficacy of Cognitive Behavioral Therapy (CBT), specifically Exposure and Response Prevention (ERP), selective serotonin reuptake inhibitors (SSRIs) such as sertraline and fluoxetine, and integrated combination paradigms. The instrument provides a granular continuum of measurement, rendering it sensitive to both partial therapeutic response (typically defined as a ≥25% or ≥30% reduction in global scores) and clinical remission (consistently operationalized across contemporary literature as a total severity score ≤ 12 or ≤ 14).

Beyond clinical trial methodology, the CY-BOCS-II fills a critical clinical utility niche within specialized outpatient and inpatient child psychiatric clinics. Pediatric presentations of OCD are notoriously heterogeneous, frequently marked by evolving symptom morphology (e.g., transitions from contamination fears to violent ego-dystonic intrusions or symmetry rituals) and significant developmental variability in self-reflection. Children often lack the metacognitive maturity or emotional vocabulary required to differentiate an obsession from general worry or to accurately quantify daily temporal duration. By incorporating a joint child-parent semi-structured interview administered by an expertly trained clinician, the CY-BOCS-II synthesizes objective caregiver observation with the child’s subjective internal experience. This triadic assessment paradigm reconciles discrepancies, illuminates covert mental rituals that parents cannot observe, and identifies systemic family accommodation patterns that skew parent-only reports.

A further theoretical and practical rationale for developing the second edition was the remediation of structural psychometric flaws that plagued the original 1997 instrument. In the first edition, the “Resistance Against Obsessions/Compulsions” items routinely generated paradoxical scores: youth with severe, chronic, or highly debilitating OCD frequently reported exhibiting no active resistance against their compulsions, having completely capitulated to their rituals to avert catastrophic distress. Under the original 5-point coding framework, zero resistance was assigned the maximum severity score of 4, artificially inflating or skewing total scores, or conversely, a child who willingly engaged in rituals without distress could be misclassified. The CY-BOCS-II modified this conceptual paradigm by restructuring the resistance item into a more developmentally robust metric—Obsession/Compulsion-Free Interval—while recalibrating the internal control item to evaluate perceived mastery without penalizing adaptive acceptance or non-confrontational strategies.

5. Psychological Construct

The overarching construct assessed by the CY-BOCS-II is Pediatric Obsessive-Compulsive Symptom Severity, conceptualized as a multi-dimensional clinical phenotype comprising cognitive intrusions and compulsive compensatory responses. Within contemporary psychometric and psychiatric paradigms, this overarching construct is operationalized through two correlated, yet distinct, primary dimensions: the Obsession Severity Dimension and the Compulsion Severity Dimension. Each dimension encompasses five distinct operational sub-constructs:

1. Temporal Burden (Time Occupied)

This sub-construct quantifies the aggregate chronological duration consumed by obsessional thoughts or compulsive rituals during waking hours. For obsessions, it measures the sheer frequency and temporal persistence of intrusive, unwanted cognitions, mental images, or urges. For compulsions, it gauges the elapsed clock time dedicated to physical routines (e.g., handwashing, checking, ordering) or covert mental acts (e.g., silent counting, neutralization prayers). In pediatric populations, temporal burden represents an essential index of cognitive exhaustion; extreme manifestations involve youth dedicating greater than 8 hours per day to obsessive rumination or repetitive motor sequences, directly arresting developmental milestones and baseline functioning.

2. Symptom-Free Intervals

Re-engineered specifically for the second edition, this sub-construct examines the longest sustained interval during waking hours that the child remains entirely liberated from intrusive thoughts or compulsive executions. Rather than asking how aggressively the patient confronts or battles the symptoms, the symptom-free interval provides an objective biological and behavioral baseline of symptom density. A youth exhibiting continuous, unremitting symptomatology without a single hour of reprieve occupies the most severe end of this construct, indicating high neurobiological vulnerability and an inability of frontostriatal circuits to down-regulate affective arousal.

3. Subjective Distress

This construct captures the phenomenological burden, emotional turmoil, and affective disturbance directly provoked by obsessions and compulsions. Within the obsessional domain, distress manifests as intense anxiety, visceral panic, disgust, moral guilt, or pervasive “not-just-right” feelings (incompleteness). Within the compulsive domain, distress is assessed along two trajectories: the acute frustration and misery experienced while trapped inside repetitive sequences, and the hypothetical or anticipated panic that emerges when ritualistic completion is blocked or prohibited by external limits or ecological barriers.

4. Functional Interference

Functional interference evaluates the secondary ecological impairment directly attributable to obsessive-compulsive manifestations. This dimension tracks impairment across four critical developmental ecosystems: academic performance (e.g., inability to complete homework due to rewriting, late arrivals caused by morning rituals), peer relationships and social integration (e.g., avoidance of playdates due to contamination fears, social alienation caused by bizarre tics or rituals), family functioning (e.g., severe conflict surrounding morning or bedtime routines, homebound states), and basic activities of daily living (e.g., catastrophic eating or toileting delays). In its most debilitating form, interference reaches a fully bedridden state, where pediatric patients become completely incapacitated.

5. Internal Regulatory Agency (Control)

The control construct measures the youth’s metacognitive ability and perceived psychological agency in arresting, diverting, dismissing, or refraining from obsessions and compulsions. Unlike the discarded “resistance” metric, control assesses execution and efficacy rather than ideological combat. For obsessions, it evaluates whether the child can successfully deploy cognitive redirection, attentional shifts, or mindfulness to dismiss an intrusive thought. For compulsions, it evaluates behavioral inhibition—specifically, whether the child possesses sufficient self-regulatory capacity to delay, interrupt, or permanently abort a compulsive motor sequence once initiated.

6. Theoretical Framework

The structural design and clinical architecture of the CY-BOCS-II are situated at the intersection of cognitive-behavioral theory, developmental psychopathology, and neurobiological models of cortico-striato-thalamo-cortical (CSTC) circuit dysfunction.

The Cognitive-Behavioral Formulation of Pediatric OCD

From an empirical behavioral perspective, the CY-BOCS-II operationalizes the classic two-stage learning model formulated by O. Hobart Mowrer, subsequently refined by cognitive theorists such as Paul Salkovskis, David A. Clark, and Jack Rachman. In this framework, obsessions originate as normal intrusive mental phenomena (e.g., fleeting blasphemous ideas, thoughts of harm, or concerns regarding micro-organisms) that undergo pathological amplification when the individual assigns catastrophic, personalized significance to their occurrence. In children, this takes the form of cognitive distortions such as thought-action fusion (believing that thinking about harm will cause harm), inflated personal responsibility, and intolerance of uncertainty.

The compulsion emerges through negative reinforcement mechanisms: performing the repetitive motor or cognitive ritual temporarily reduces the profound visceral distress elicited by the intrusive obsession. Because the ritual successfully terminates or prevents the perceived catastrophic outcome, the compulsion is operantly reinforced, establishing a chronic behavioral loop. The CY-BOCS-II explicitly maps this behavioral loop: Items 1–5 measure the frequency and distress of the conditioned stimulus (the obsession), while Items 6–10 measure the negative-reinforcement loop and the child’s collapsing inhibitory control over the ritualistic response (the compulsion).

Developmental Psychopathology and Metacognition

Developmental psychopathology asserts that psychiatric phenomena in children cannot be conceptualized merely as miniature replicas of adult syndromes. Children exhibit continuous structural changes in executive functioning, linguistic maturity, and metacognitive monitoring. Jean Piaget’s stages of cognitive development and contemporary developmental neurobiology demonstrate that abstract operational thinking and metacognition—the capacity to monitor and critically reflect upon one’s own internal cognitive processes—develop gradually throughout late childhood and adolescence.

Consequently, pediatric patients with OCD frequently exhibit poor insight or non-ego-dystonic presentations. A young child may not conceptualize their intrusive urge as unreasonable or irrational, but rather as an absolute physical necessity to avoid real-world catastrophe (e.g., “If I do not tap the table 10 times, an earthquake will destroy our home”). The CY-BOCS-II accommodates these developmental realities through its semi-structured clinician-guided interview format. By combining clinical observation, child interview, and collateral caregiver reporting, the instrument bridges the child’s emerging self-awareness and the parent’s external observation of behavioral parameters, avoiding the diagnostic blind spots inherent to self-report questionnaires.

Neurobiological Correlates

Contemporary cognitive neuroscience characterizes OCD as an impairment in neurobehavioral action control, mediated by hyperactive structural and functional loops within the cortico-striato-thalamo-cortical (CSTC) pathways, linking the orbitofrontal cortex (OFC), anterior cingulate cortex (ACC), and striatum (caudate nucleus). In healthy individuals, the basal ganglia filter unwanted thoughts and allow smooth behavioral transitions. In pediatric OCD, hyperactive circuit reverberation produces failure of automated behavioral inhibition, leading to stereotypic compulsions and inability to shift cognitive focus. The CY-BOCS-II severity metrics—particularly time occupied, symptom-free intervals, and regulatory control—serve as precise clinical proxies for the degree of CSTC circuit disinhibition.

7. Validity

The CY-BOCS and its second edition have been subjected to rigorous construct, convergent, discriminant, and predictive validation across diverse pediatric psychiatric cohorts internationally.

Convergent Validity

Convergent validity is documented through robust, statistically significant correlations between the CY-BOCS-II and alternative validated pediatric OCD measures. Evaluations conducted by Storch et al. (2010), Scahill et al. (1997), and subsequent psychometric replications have shown that the CY-BOCS-II Total Severity Score correlates strongly with:

• The Clinical Global Impressions – Severity scale (CGI-S) adapted for OCD (Pearson $r$ values ranging from .65 to .78, $p < .001$), confirming that the dimensional score reliably tracks global clinical judgment.
• Child- and parent-rated self-report scales, such as the Obsessive-Compulsive Scale of the Child Behavior Checklist (CBCL-OCS) ($r = .52$ to $.64$) and the Multidimensional Anxiety Scale for Children (MASC) OCD subscale ($r = .58$ to $.69$).
• The Child OCD Impact Scale (COIS) ($r = .60$ to $.73$), demonstrating that higher CY-BOCS-II scores directly align with objective assessments of functional disability across school, social, and home environments.

Discriminant Validity

A critical psychometric hurdle for any anxiety-related instrument is ensuring that it measures obsessive-compulsive phenomena rather than non-specific negative affect, generalized anxiety, or depressive demoralization. The CY-BOCS-II demonstrates exceptional discriminant validity:

• Correlations between the CY-BOCS-II Total Severity Score and depressive symptom measures—such as the Children’s Depression Inventory (CDI)—are typically low to moderate ($r = .25$ to $.38$), indicating that while secondary depressive distress frequently co-occurs in youth with severe OCD, the instrument does not conflate depression with OCD pathology.
• Correlations with generalized anxiety measures—such as the Revised Children’s Manifest Anxiety Scale (RCMAS) or the generalized anxiety subscales of the Screen for Child Anxiety Related Emotional Disorders (SCARED)—remain significantly lower ($r = .30$ to $.42$) than the correlations observed between the CY-BOCS-II and dedicated OCD indices.
• The scale successfully discriminates children with confirmed primary OCD from clinical pediatric cohorts diagnosed with Attention-Deficit/Hyperactivity Disorder (ADHD), Tourette syndrome / Tic Disorders, and Autism Spectrum Disorder (ASD), establishing that stereotypic behaviors or simple motor tics are not erroneously coded as complex compulsions when administered by trained interviewers.

Predictive and Treatment Sensitivity (Criterion Validity)

The instrument has repeatedly exhibited sensitivity to therapeutic intervention. Across clinical trials of SSRIs and manualized Exposure and Response Prevention (such as POTS, 2004), the CY-BOCS-II reliably captured incremental, week-by-week behavioral improvements. Post-treatment CY-BOCS-II scores strongly predict long-term diagnostic remission and downstream functional restoration, establishing its high criterion and predictive validity.

8. Reliability

The CY-BOCS-II exhibits exceptional reliability across internal consistency, inter-rater concordance, and temporal stability (test-retest reliability).

Internal Consistency

Extensive psychometric investigations of the CY-BOCS-II across outpatient clinics and randomized controlled trials report high internal consistency across all subscale dimensions:

• Obsession Severity Subscale: Cronbach’s $\alpha$ coefficients consistently range from .86 to .88; McDonald’s $\omega$ values similarly exceed .87.
• Compulsion Severity Subscale: Cronbach’s $\alpha$ coefficients consistently range from .89 to .91, reflecting high internal item coherence.
• Total Severity Composite (10 Items): The aggregate scale demonstrates an overall internal consistency between $\alpha = .90$ and $.93$. Corrected item-total correlations across all 10 individual items consistently surpass .55, with no single item removal improving aggregate scale alpha.

Inter-Rater Reliability

Because the CY-BOCS-II is a clinician-rated semi-structured interview, inter-rater reliability is vital. In calibration studies where independent clinicians scored live or video-recorded patient interviews, inter-rater reliability statistics were outstanding:

• The Intraclass Correlation Coefficient (ICC) for the Total Severity Score exceeds .95 (frequently spanning .94 to .98, $p < .001$).
• Subscale ICCs remain high: Obsession Severity Subscale ICC $\approx .91$ to $.95$; Compulsion Severity Subscale ICC $\approx .93$ to $.97$.
• Cohen’s $kappa$ for individual item categorization across trained evaluators ranges from .82 to .94, confirming that the standardized scoring anchors provide unambiguous guidance for clinicians.

Test-Retest Reliability

In stable clinical samples re-evaluated across a 1- to 2-week baseline interval prior to active intervention, the CY-BOCS-II demonstrates robust temporal stability. Test-retest correlation coefficients consistently range between $r = .85$ and $r = .92$ for the Total Severity Score. This stability confirms that baseline fluctuations do not introduce uncontrolled variance into repeated-measures trial protocols.

9. Factor Analysis

Structural evaluations using Exploratory Factor Analysis (EFA) and Confirmatory Factor Analysis (CFA) have rigorously established the latent factorial architecture of the CY-BOCS and the CY-BOCS-II.

Exploratory Factor Analysis (EFA)

Early structural investigations of the original CY-BOCS by Scahill et al. (1997) and Storch et al. (2005) identified a two-factor latent structure accounting for greater than 60% of total shared variance. The items clearly clustered into an Obsession Severity Factor (Items 1–5) and a Compulsion Severity Factor (Items 6–10). However, within the original edition, the “Resistance” items exhibited low factor loadings (often $< .40$) and cross-loaded across both dimensions, signaling psychometric ambiguity. With the structural transition to the CY-BOCS-II—wherein Resistance was replaced by Symptom-Free Interval—subsequent EFA extractions revealed substantially cleaner solutions. Factor 1 (Compulsions) and Factor 2 (Obsessions) uniformly exhibited strong, clean loadings without problematic cross-loadings:

• Compulsion Items (6–10): Factor loadings range between .68 and .88 on the Compulsion latent factor, with minimal cross-loading on Obsessions ($< .20$).
• Obsession Items (1–5): Factor loadings range between .64 and .85 on the Obsession latent factor, with minimal cross-loading on Compulsions ($< .22$).

Confirmatory Factor Analysis (CFA)

Subsequent validation studies evaluating alternative structural configurations using CFA have definitively favored the Two-Factor Correlated Model over a unidimensional single-factor model. Goodness-of-fit parameters across modern structural equation modeling studies consistently demonstrate strong fit:

• Comparative Fit Index (CFI): Values consistently range from .95 to .98 (exceeding the standard $ge .95$ benchmark).
• Tucker-Lewis Index (TLI): Values range between .94 and .97.
• Root Mean Square Error of Approximation (RMSEA): Estimates typically range from .045 to .062 (with 90% confidence intervals below .08), demonstrating minimal residual error.
• Standardized Root Mean Square Residual (SRMR): Values remain below .050.

While the two latent factors correlate moderately to strongly ($r \approx .55$ to $.70$), reflecting the clinical reality that intrusive cognitions and behavioral rituals coexist within the vast majority of pediatric patients, nesting the items into two distinct subscales remains statistically and clinically justified.

10. Instrument / Measurement Tool

The structural characteristics, administrative guidelines, and scoring protocols for the Children’s Yale-Brown Obsessive Compulsive Scale – Second Edition (CY-BOCS-II) are summarized below:

• Instrument Name: Children’s Yale-Brown Obsessive Compulsive Scale – Second Edition (CY-BOCS-II).
• Target Population: Children and adolescents aged 8 through 17 years presenting with known or suspected obsessive-compulsive symptomatology. (Can be adapted developmentally for younger children with high parental collateral input).
• Instrument Typology: Semi-structured, clinician-administered, multi-informant psychiatric interview.
• Administration Duration: Approximately 45 to 75 minutes for a comprehensive initial baseline evaluation (including the Symptom Checklist); approximately 20 to 30 minutes for serial post-baseline Severity Scale follow-up ratings.
• Administrative Structure:
  • Component 1 (Symptom Checklist): An extensive categorical inventory screening for historical (lifetime) and current (active over the preceding 30 days) manifestations across thematic clusters: Contamination, Aggression/Harm, Sexual/Somatic/Religious, Symmetry/Exactness, and Miscellaneous Obsessions; followed by Cleaning/Washing, Checking, Repeating, Counting, Ordering/Arranging, Hoarding, and Miscellaneous Compulsions. The clinician uses this checklist to establish the child’s Target Symptoms.
  • Component 2 (Severity Scale): A 10-item quantitative metric evaluating the specific target symptoms identified in Component 1. The first 5 items measure Obsessions; the subsequent 5 items measure Compulsions.
• Response Scale Metric: An expanded 6-point anchored ordinal scale (scored 0, 1, 2, 3, 4, or 5) tailored specifically for each item dimension:
  • Items 1 & 6 (Time Occupied): 0 = None; 1 = Mild (less than 1 hr/day); 2 = Moderate (1 to 3 hrs/day); 3 = Severe (greater than 3 and up to 8 hrs/day); 4 = Extreme (greater than 8 hrs/day); 5 = Constant/Nearly continuous.
  • Items 2 & 7 (Obsession/Compulsion-Free Interval): 0 = No symptoms; 1 = Long symptom-free interval (more than 8 consecutive waking hours free); 2 = Moderately long symptom-free interval (more than 3 and up to 8 consecutive waking hours free); 3 = Short symptom-free interval (from 1 to 3 consecutive waking hours free); 4 = Extremely short symptom-free interval (less than 1 consecutive waking hour free); 5 = Continuous/No symptom-free waking intervals.
  • Items 3 & 8 (Distress): 0 = None; 1 = Mild, infrequent distress; 2 = Moderate, frequent distress; 3 = Severe, very frequent distress; 4 = Extreme, near constant disabling distress; 5 = Disabling, completely incapacitated by distress.
  • Items 4 & 9 (Interference): 0 = None; 1 = Mild, slight interference with social, school, or other activities; 2 = Moderate, definite interference with social, school, or other activities; 3 = Severe, substantial impairment in social, school, or other activities; 4 = Extreme, incapacitating; 5 = Bedridden/Completely unable to function.
  • Items 5 & 10 (Control): 0 = Complete control; 1 = Much control (usually able to stop or divert); 2 = Moderate control (sometimes able to stop or divert); 3 = Little control (rarely successful in stopping or diverting); 4 = Very little control (can only divert attention with difficulty); 5 = No control (completely involuntary).
• Scoring and Categorical Interpretations:
  • Obsession Severity Subscale Score: Sum of Items 1 through 5 (Range: 0–25).
  • Compulsion Severity Subscale Score: Sum of Items 6 through 10 (Range: 0–25).
  • Total CY-BOCS-II Severity Score: Aggregate sum of all 10 items (Range: 0–50).
  • Clinical Severity Cut-Off Stratifications:
    • 0 – 7: Subclinical / Inactive or in Full Remission
    • 8 – 15: Mild OCD symptomatology
    • 16 – 23: Moderate OCD symptomatology (common inclusion baseline for clinical trials)
    • 24 – 31: Severe OCD symptomatology
    • 32 – 50: Extreme / Incapacitating OCD symptomatology

11. Permissions & Fee and Test Year

The original Children’s Yale-Brown Obsessive Compulsive Scale was published in 1997 by Scahill, Riddle, and colleagues, building on the foundational adult Y-BOCS published in 1989 by Goodman et al. The revised Children’s Yale-Brown Obsessive Compulsive Scale – Second Edition (CY-BOCS-II) was introduced following the development of the adult second edition by Storch, Goodman, and colleagues in 2010.

Licensing and Fee Structure: The CY-BOCS-II is considered non-commercial public-domain academic intellectual property and is freely available for routine clinical practice, public health initiatives, and independent academic research without mandatory per-use copyright purchase fees. However, formal administrative guidelines require that:

• When utilized within formal grant-funded clinical research trials, industry-sponsored pharmacological trials, or multi-center outcome registries, investigators must contact the primary copyright holders and corresponding authors (e.g., Dr. Wayne K. Goodman or Dr. Eric A. Storch) to secure formal operational permission, register the protocol, and obtain authorized master interview protocols.
• Any commercial digital reproduction, integration into proprietary Electronic Medical Record (EMR) software platforms, or automated digital scoring engines requires explicit written licensing agreements from the intellectual property owners.
• Clinicians and research evaluators must complete rigorous didactic training and calibration against gold-standard taped administrations to ensure adequate inter-rater concordance before serving as formal study raters.

12. References

Goodman, W. K., Price, L. H., Rasmussen, S. A., Mazure, C., Fleischmann, R. L., Hill, C. L., Heninger, G. R., & Charney, D. S. (1989). The Yale-Brown Obsessive Compulsive Scale: I. Development, use, and reliability. Archives of General Psychiatry, 46(11), 1006–1011. https://doi.org/10.1001/archpsyc.1989.01810110048007

Pediatric OCD Treatment Study (POTS) Team. (2004). Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: The Pediatric OCD Treatment Study (POTS) randomized controlled trial. JAMA, 292(16), 1969–1976. https://doi.org/10.1001/jama.292.16.1969

Scahill, L., Riddle, M. A., McSwiggin-Hardin, M., Ort, S. I., King, R. A., Goodman, W. K., & Cicchetti, D. (1997). Children’s Yale-Brown Obsessive Compulsive Scale: Reliability and validity. Journal of the American Academy of Child & Adolescent Psychiatry, 36(6), 844–852. https://doi.org/10.1097/00004583-199706000-00023

Storch, E. A., Murphy, T. K., Geffken, G. R., Soto, O., Sajid, M., Allen, P., Roberti, J. W., Killiany, E. M., & Goodman, W. K. (2005). Psychometric evaluation of the Children’s Yale-Brown Obsessive-Compulsive Scale. Psychiatry Research, 137(3), 173–185. https://doi.org/10.1016/j.psychres.2005.06.012

Storch, E. A., Rasmussen, S. A., Price, L. H., Larson, M. J., Murphy, T. K., & Goodman, W. K. (2010). Development and psychometric evaluation of the Yale-Brown Obsessive-Compulsive Scale—Second Edition. Psychological Assessment, 22(2), 223–232. https://doi.org/10.1037/a0018492

13. Items of the Scale (Questionnaire)